Company Filing History:
2 out of 61 
1 out of 417 
1 out of 4 Years Active: 2019-2025
Title: Hajime Kurosaki: Innovator in Vaccinia Virus Research
Introduction
Hajime Kurosaki is a notable inventor based in Yonago, Japan. He has made significant contributions to the field of virology, particularly in the development of vaccinia viruses for therapeutic applications. With a total of 3 patents, his work focuses on innovative methods to induce cell fusion and combat cancer.
Latest Patents
Kurosaki's latest patents include groundbreaking inventions such as a vaccinia virus that induces cell fusion between infected cells. This invention provides a method for producing a vaccinia virus that is deprived of the K2L gene or the HA gene, mutated to induce cell fusion and cell death. Another significant patent involves genetically engineered vaccinia viruses that are effective in preventing or treating cancer. This recombinant virus lacks functions of VGF and O1L and includes a gene encoding B5R with a deleted SCR domain. Additionally, he has developed a combination kit of two vaccinia viruses, each encoding IL-7 and IL-12, for enhanced therapeutic use.
Career Highlights
Throughout his career, Hajime Kurosaki has worked with esteemed institutions such as Tottori University and Astellas Pharma GmbH. His research has been pivotal in advancing the understanding and application of vaccinia viruses in medical treatments.
Collaborations
Kurosaki has collaborated with notable colleagues, including Takafumi Nakamura and Motomu Nakatake, contributing to the advancement of his research and innovations.
Conclusion
Hajime Kurosaki's work in the field of vaccinia virus research exemplifies the impact of innovative thinking in medicine. His patents reflect a commitment to developing effective treatments for serious health conditions.